Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Privia Health Group Inc shares valued at $2,500,127 were sold by Mehrotra Parth on Sep 10 ’24. At $18.50 per share, Mehrotra Parth sold 135,142 shares. The insider’s holdings dropped to 247,771 shares worth approximately $4.49 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Mehrotra Parth purchased 135,142 shares, netting a total of over 2,500,719 in proceeds.
Before that, Boehler Adam had added 364 shares to its account. In a trade valued at $6,006, the Director bought Privia Health Group Inc shares for $16.50 each. Upon closing the transaction, the insider’s holdings increased to 364 shares, worth approximately $104.56 million.
As published in their initiating research note from KeyBanc Capital Markets on October 11, 2024, Privia Health Group Inc [PRVA] has been an Overweight and the price target has been revised to $23. Analysts at Robert W. Baird started covering the stock with ‘”an Outperform”‘ outlook in a report released in late May. As of April 22, 2024, Citigroup has initiated its “Buy” rating for PRVA. Earlier on March 06, 2024, Barclays initiated its rating. Their recommendation was “an Equal weight” for PRVA stock.
Analyzing PRVA Stock Performance
During the last five days, there has been a surge of approximately 7.67%. Over the course of the year, Privia Health Group Inc shares have dropped approximately -21.36%. Shares of the company reached a 52-week high of $24.05 on 01/02/24 and a 52-week low of $15.92 on 05/21/24. A 50-day SMA is recorded $18.79, while a 200-day SMA reached $19.17. Nevertheless, trading volume fell to 0.67 million shares from 0.66 million shares the previous day.
Support And Resistance Levels for Privia Health Group Inc (PRVA)
According to the 24-hour chart, there is a support level at 17.85, which, if violated, would cause prices to drop to 17.59. In the upper region, resistance lies at 18.26. The next price resistance is at 18.41. RSI (Relative Strength Index) is 51.04 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.27, which suggests the price will decrease in the coming days. Percent R is at 17.17%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
